AIRE:NASDAQ, reAlpha Tech Corp.

AIRE stock overview

reAlpha Tech Corp. (AIRE:NASDAQ) closed at $1.02 on October 21, 2026, up 12.48% on the day. The stock trades 96.9% below its 52-week high of $32.50 and 21.4% above its 52-week low of $0.840. reAlpha Tech Corp. is part of the Health Care sector.

Key figures

Price
$1.02
Day change
+12.48%
Volume
50,286
Average volume
110,126
Market cap
6M+
52-week range
$0.840 – $32.50
50-day average
$1.39
200-day average
$4.34

Price action over the past year

In 251 trading sessions since October 21, 2025, AIRE closed higher on 105 days (42%). Its best day was October 21, 2025 (+61.42%) and its worst was April 28, 2026 (-33.58%). The stock moved 10% or more in a single session 29 times. It opened at least 5% above the previous day's high 5 times.

Recent signals

AIRE news

About reAlpha Tech Corp.

Bio-Techne Corporation is a global life sciences company. The Company is engaged in providing tools and bioactive reagents for the research and clinical diagnostic communities. It operates through two segments: Protein Sciences and Diagnostics and Genomics. Its Protein Sciences segment develops and manufactures biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. This segment also includes proteomic analytical tools, both manual and automated, that offer researchers and pharmaceutical manufacturers efficient and streamlined options for automated western blot and multiplexed ELISA workflow. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits.

Similar stocks

Find more stocks like AIRE with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.